Daraprim drug’s key ingredient recreated by high school students in Sydney for just $20

By Raveen Hunjan For $US20, a group of high school students has created 3.7 grams of an active ingredient used in the medicine Daraprim, which would sell in the United States for between $US35,000 and $US110,000. Read more…
Continue Reading →

WSJ: Why competition drives drug prices up, not down

 By Mackenzie Bean  While it is a common belief that more competition in the pharmaceutical industry will help contain high drug costs, Pfizer and Eli Lilly’s rivalry over their erectile dysfunction drugs proves otherwise. In June, New York City-based Pfizer raised the price of
Continue Reading →

How health systems across the US are improving price transparency

By Kelly Gooch  Physician organizations, hospitals and health systems are under increasing pressure to deliver transparent, competitive pricing. This pressure is coming from multiple sources, according to Igor Belokrinitsky, principal with Strategy&, PricewaterhouseCoopers’
Continue Reading →

AMA Pledges to Prevent Loss of Americans’ Healthcare Coverage

By Vera Gruessner The American Medical Association (AMA) released a statement yesterday reaffirming its commitment to ensuring that every American who currently has healthcare coverage will continue to have insurance and access to medical care. Read more…
Continue Reading →

In New Survey Of Eleven Countries, US Adults Still Struggle With Access To And Affordability Of Health Care

By Eric C. Schneider Surveys of patients’ experiences with health care services can reveal how well a country’s health system is meeting the needs of its population. Using data from a 2016 survey conducted in eleven countries—Australia, Canada, France, Germany, the Netherlands, New Ze
Continue Reading →

‘Somewhere in between’: Finding the balance between quality and the bottom line

By Kelly Gooch As healthcare continues its shift from fee-for-service to value-based care, hospitals and health systems are working steadily to try and improve quality while reducing costs. However, striking a balance between the two can be challenging. Read more…
Continue Reading →

Repeal and replace Obamacare? It’s not gonna be easy

By Harris Meyer  | November 12, 2016 President-elect Donald Trump and congressional Republican leaders are promising to make repeal and replacement of the Affordable Care Act one of their highest priorities in the first 100 days after they take full control of the federal government i
Continue Reading →

Repealing The Affordable Care Act Could Be More Complicated Than It Looks

By Julie Rovner After six controversial years, the Affordable Care Act, aka Obamacare, may be on the way out, thanks to the GOP sweep of the presidency and both houses of Congress Tuesday. “There’s no question Obamacare is dead,” said insurance industry consultant Robert Laszewski. “T
Continue Reading →

Health-care stocks skyrocket after Donald Trump stuns market with White House win

By Fred Imbert Health-care companies saw their stocks shoot through the roof on Wednesday after Republican Donald Trump‘s shocking White House victory. Shares of Dow component Pfizer and Mylan rose 7 percent and 4.8 percent Wednesday, respectively. Allergan and Amgen shares foll
Continue Reading →

How Could a New Administration Tackle Affordable Care Act Challenges? Look to Medicare

By Sabrina Corlette and Jack Hoadley We’re experiencing another round of bad headlines for the Affordable Care Act (ACA) marketplaces. A government report found that, on average, premiums will rise 25 percent and consumers will have fewer insurance company choices in 2017. Eighty-thre
Continue Reading →